Researchers at UQ’s Queensland Brain Institute (QBI) have highlighted how acetylcholine signalling interacts with dopamine pathways in the brain, findings that may help explain how a new class of schizophrenia treatments works.
QBI's Professor Eyles and his team have developed a novel intranasal formulation of the antipsychotic drug, clozapine, that may revolutionise the treatment of schizophrenia.
Antipsychotic drugs, like clozapine, can stabilise some schizophrenia symptoms, but they do not cure the illness and can cause severe side effects. QBI's Professor Darryl Eyles and Dr Xiaoying Cui are investigating a new delivery mode for clozapine.
From increasing our brain’s resilience to stress to possible novel immunotherapy treatments for depression, Queensland Brain Institute (QBI) scientists continue to lead the way in mental health advances.
We constantly make choices, but for some people suffering from illnesses such as schizophrenia and substance use disorder – previously referred to as “substance abuse” – making the right choices can be extremely difficult.